The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD
In this study, with real-life patient data, long-term follow-up and a well-matched control group, we found that tolvaptan attenuated long-term kidney function decline but seemed not to influence kidney growth.
Authors
- Ron T. Gansevoort (ORCID: https://orcid.org/0000-0002-3223-0906)
- Esther Meijer (ORCID: https://orcid.org/0000-0001-7875-1793)
- Martine Knol (ORCID: https://orcid.org/0009-0007-1780-4899)
- Priya Vart (ORCID: https://orcid.org/0000-0001-5576-820X)
- Paul Geertsema (ORCID: https://orcid.org/0000-0003-1376-9727)
- Niek F. Casteleijn
- Thomas Bais (ORCID: https://orcid.org/0009-0008-3649-6948)
- Vera Kuiken
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- St. Anna Ziekenhuis (NL)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1093/ndt/gfaf048
- Citations
- 3
- Primary Topic
- Biomedical Research and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 4.41